Skip to main content

July 2013

academics

 

Clinical research courses

Applications are invited for the post of Research Associate in University of Pune - 2 posts

Applications are invited in the following Proforma for the post of Research Associate in the Department of Environmental Science for the academic year 2013-2014.

Post: Research Associate

STUDIES IN CONCURRENT PROCESS VALIDATION OF CEFIXIME DISPERSIBLE TABLET I.P.

ABOUT AUTHORS:
Mr. Diptesh A. Patel1*, Mrs. Pinkal H. Patel1, Mr. Rohit K. Patel2
1Department of Quality Assurance, Baroda college of pharmacy, Vadodara, Gujarat, India.
2Department of Quality Assurance, Kaptab Pharmaceutical, Vadodara, Gujarat, India.
*dipteshpatel88@yahoo.com

PH-STIMULI SENSITIVE POLYMER AS A CARRIER FOR TARGETED DELIVERY SYSTEM: A REVIEW

ABOUT AUTHORS:
Girish Kumar Tripatha*, Satyawan Singha
Bio-organic chemistry Laboratory,
Saroj Institute of Technology & Management Lucknow, India
*orgpharm@gmail.com

Opportunity for Manager Quality Assurance in Novartis

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

IBSD invites Senior Research Fellow, Laboratory Assistant

Institute of Bioresearches and Sustainable Development (IBSD), Imphal, a research institute under Department of Biotechnology, Govt. of India, invites applications from the suitable candidates for the following positions for its extramural research project funded by Department of Biotechnology, Govt. of India. Prescribed application format is available at the Institute’s website or from the receptionist of the Institute.

Required for Research Fellow in Indian Institute of Chemical Biology

Applications are invited for the post of Research Associate in NII

The National Institute of Immunology (NII) is an autonomous institution supported by the Department of Biotechnology, Government of India. The Institute is committed to advanced research addressing the basic mechanisms involved in body's defense, host-pathogen interactions and related areas with a view to contribute to the creation of an internationally competitive intellectual knowledge base as a sustainable source of innovative futuristic modalities of potential use in health care.

Join in for posts of Lab Technician, Social/Field Worker in ILS

Institute of Life Sciences (ILS), Bhubaneswar, an autonomous Institute of the Department of Biotechnology, Ministry of Science & Technology, Government of India is an emerging multidisciplinary institute engaged in advanced research invites applications from Indian Nationals to join in the following posts in DST sponsored project entitled “Investigation of the gene expression and characterization of selected genes associated with otosclerosis”.

A REVIEW ON NEEDLE-FREE INJECTION SYSTEMS: NOVEL APPROACH TO DRUG DELIVERY

About Authors:
Waghmare P.V.*, Chinchole A.S.1, Chavan D.V.2, Dr.Bhusnure O.G.3
Master of pharmacy, Department of Quality Assurance (*,1, 2,3)
Maharashtra College of Pharmacy, Nilanga, Dist. Latur (MS) 413521, India
*pradeep.waghmare90@gmail.com

A BRIEF REVIEW ON TREATMENT & PREVENTION OF CANCER

ABOUT AUTHORS:
Saurabh Kumar Singh*, Aruna Chandra Singh
Department of pharmaceutical Chemistry, Rajiv Academy for pharmacy, Mathura,
N.H. #2 Delhi-Mathura Bye-pass, P.O. Chhatikara,
Mathura-281001.Uttar Pradesh, India
*s_s_khirwar@yahoo.co.in

ABSTRACT
The rate of cancer rise is dramatic, doubling in the last 30 years. Furthermore, of the estimated 560,000 cancer victims who would die in 1997, most of them could have prevented their illness had they paid attention to some simple lifestyle factors.

Although the number of cancer deaths continues to rise each year in the U.S., the per capita cancer mortality rate has just recently started to decline. This celebrated small decline was first announced by the National Cancer Institute in late 1996, but a careful retrospective review of the data indicated that the per capita cancer death rate peaked in 1991 and has ever so slowly declined thereafter. What was the reason for this decline? Not improved cancer treatments, but cancer prevention itself emerges as the cause for this good news. A national commitment to the prevention of cancer, largely replacing reliance on hopes for universal cures.